GAMIFANT
NDC 66658-522, emapalumab-lzsg, injection, from Swedish Orphan Biovitrum AB (publ).
- Product NDC
- 66658-522
- Status
- Listed
- Labeler
- Swedish Orphan Biovitrum AB (publ)
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761107
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66658-522 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EMAPALUMAB50 mg/2mL
Pharmacologic classes
Interferon gamma Antagonists [MoA]; Interferon gamma Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66658-522-01 | 66658052201 | 1 VIAL, SINGLE-USE in 1 CARTON (66658-522-01) / 2 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a865e0ef-8685-4f69-8838-648c4f3bab47
Use it
Look up 66658-522 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66658-522 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66658-522. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.